NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues.

Author(s): Hwang SI, Thumar J, Lundgren DH, Rezaul K, Mayya V, Wu L, Eng J, Wright ME, Han DK

Publication: Oncogene, 2007, Vol. 26, Page 65-76

PubMed ID: 16799640 PubMed Review Paper? No

Purpose of Paper

purpose of this paper was to determine the relative efficiencies of extraction buffers used for protein recovery in paraformaldehyde fixed paraffin embedded (PFPE) specimens.

Conclusion of Paper

Using PFPE coronary artery, only 13.5% as much protein was extracted using a buffer containing 30% acetonitrile and 100 mM ammonium bicarbonate (buffer A) as was extracted using a solution containing 2% sodium dodecyl sulfate in radioimmunoprecipitation assay buffer (buffer D). Using PFPE prostate tissue arrays, 47.4% of the protein extracted with buffer D was extracted with buffer A, while 77% more protein was extracted with 0.1% RapiGest in 50 mM NH4HCO3 (buffer E) than with buffer D. The authors conclude that if enough specimen is available, buffer D should be used preferentially, but buffer A is compatible with liquid chromatography mass spectrophotometry.

Studies

  1. Study Purpose

    The purpose of this study was to determine the relative efficiencies of extraction buffers used for protein recovery in a PFPE coronary artery specimen and prostate tissue array specimens.

    Summary of Findings:

    Using PFPE coronary artery, only 13.5% as much protein was extracted using a buffer containing 30% acetonitrile and 100 mM ammonium bicarbonate (buffer A) as was extracted using a solution containing 2% sodium dodecyl sulfate in radioimmunoprecipitation assay buffer (buffer D). Using PFPE prostate tissue arrays, 47.4% of the protein extracted with buffer D was extracted with buffer A, while 77% more protein was extracted with 0.1% RapiGest in 50 mM NH4HCO3 (buffer E) than with buffer D. The authors conclude that if enough specimen is available, buffer D should be used preferentially, but buffer A is compatible with liquid chromatography mass spectrophotometry.

    Biospecimens
    Preservative Types
    • Other Preservative
    Diagnoses:
    • Normal
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein 1D/2D gels
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Analyte Extraction and Purification Analyte isolation method 0.1% RapiGest in 50 mM NH4HCO3
    30% acetonitrile and 100 mM ammonium bicarbonate,
    2% sodium dodecyl sulfate in radioimmunoprecipitation assay (RIPA) buffer
    Biospecimen Acquisition Biospecimen location Prostate
    Coronary artery

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...